What is Fertilis?
Fertilis is an innovative medical device company based in Adelaide, South Australia, focused on revolutionizing the In Vitro Fertilization (IVF) process. The company has developed a proprietary IVF technology that automates key aspects of the procedure. Central to their innovation is a patented micro-3D printed pod designed to house each embryo individually. This unique pod not only safeguards the embryo but also facilitates automated, subtle adjustments to the nutrient solutions it is bathed in, aiming to optimize embryo development.
How much funding has Fertilis raised?
Fertilis has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2022): $2.5M with participation from Horizons Ventures
Key Investors in Fertilis
Horizons Ventures
Horizons Ventures focuses on investing in deep science and technology aimed at advancing humanity towards a significantly improved future. The company seeks to support innovative projects that have the potential to create transformative changes.
What's next for Fertilis?
With a significant enterprise-level funding context, Fertilis is poised for substantial scaling and further technological advancement. The recent major strategic investment suggests strong validation from backers, likely enabling the company to expand its research and development efforts, enhance its patented pod technology, and potentially broaden its market reach. This capital infusion is expected to accelerate Fertilis's mission to automate and improve the IVF process, making it more efficient and effective.
See full Fertilis company page
